Concepedia

Hemi Dimant

HD

Statistics

Publications

7

Citations

419

H-Index

7

Active since

2009

Affiliations

Massachusetts General Hospital(Current)

Harvard University

MaineGeneral Medical Center

Mayo Clinic in Florida

Tel Aviv University

Hemi Dimant is an author at Massachusetts General Hospital specializing in neuroscience, molecular neuroscience, and alpha-synuclein aggregation.

ORCID

Publications per year

2009–2019

7

Publications

7

Exosome-associated AAV vector as a robust and convenient neuroscience tool

Eloïse Hudry, C. Martin, Sunil Gandhi et al. · Gene Therapy · 2016 · 145 citations · Full text

, , +6

Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging

Curt Mazur, Berit Powers, Kenneth Zasadny et al. · JCI Insight · 2019 · 107 citations · Full text

, , +13

Direct detection of alpha synuclein oligomers in vivo

Hemi Dimant, Suneil K. Kalia, Lorraine V. Kalia et al. · Acta Neuropathologica Communications · 2013 · 77 citations · Full text

, , +17

Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not α-Synuclein-Induced Neuronal Cell Loss

Nikolaus R. McFarland, Hemi Dimant, Laura N. Kibuuka et al. · PLoS ONE · 2014 · 47 citations · Full text

, , +17

Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics

Hemi Dimant, Liya Zhu, Laura N. Kibuuka et al. · PLoS ONE · 2014 · 18 citations · Full text

, , +17

1–5 of 7